Agios Pharmaceuticals (AGIO) Ownership - Who owns Agios Pharmaceuticals?

Industry: @Biotechnology
10 days until earnings call

Profile

Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.65B
P/E Ratio
N/A
Total Cash
597.99M
Projected Growth
N/A
Total Debt
68.35M
Revenue
29.4M
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
10.53
Total Debt/Equity
N/A
Revenue/Share
0.53 USD as % of share price

Fundamentals

AGIO
Capitalization
2.65B
P/E Ratio
N/A
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
598M
Total Cash/Share
10.53
Total Debt
68.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.53%
Revenue
29.4M
ROE
N/A
Book Value
744M
P/B Ratio
3.56
Cash Flow
N/A
Earnings
-6.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
73K
Current Ratio
12.84
Current Revenue Per Employee
21215.03
Dividends Per Share - Security
N/A
EBITDA
-386.76M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.34
Revenue To Assets
-35.24
Shares Held By Institutions
4.12B
Shares Outstanding - Current
56.8M
Total Liabilities
106M
Total Volume MTD
N/A
Value
N/A
Gain YTD
109.295
View a ticker or compare two or three
AGIO
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com